Sofinnova Investments’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-46,386
Closed -$4.03M 80
2021
Q2
$4.03M Sell
46,386
-8,409
-15% -$678K 0.24% 55
2021
Q1
$4.52M Buy
54,795
+41,298
+306% +$3.96M 0.28% 50
2020
Q4
$1.23M Sell
13,497
-27,903
-67% -$1.73M 0.08% 62
2020
Q3
$1.65M Buy
+41,400
New +$1.45M 0.13% 63
2020
Q2
Sell
-36,564
Closed -$812K 83
2020
Q1
$812K Sell
36,564
-598,579
-94% -$15.1M 0.08% 62
2019
Q4
$12.4M Buy
635,143
+253,543
+66% +$4.03M 0.92% 25
2019
Q3
$5.93M Buy
+381,600
New +$7.31M 0.56% 40
2019
Q2
Sell
-203,742
Closed -$3.58M 77
2019
Q1
$3.58M Sell
203,742
-26,071
-11% -$412K 0.37% 47
2018
Q4
$2.95M Buy
229,813
+124,922
+119% +$1.74M 0.37% 47
2018
Q3
$1.71M Buy
+104,891
New +$1.24M 0.15% 53

Other funds holding FATE